Wetzler, M
Kantarjian, H M
Nicolini, F E
Lipton, J H
Akard, L
Baccarani, M
Khoury, H J
Li, E
Munteanu, M
Cortes, J
Article History
First Online: 11 December 2015
Competing interests
: Meir Wetzler reported personal fees from Teva, Ariad and Boehringer Ingelheim, and grants from Bristol–Myers Squibb during the conduct of the study. Hagop M Kantarjian reports research grants from Teva during the conduct of the study. Michele Baccarani reports personal fees from Ariad, Bristol–Myers Squibb, Pfizer and Novartis during the conduct of the study. Franck E Nicolini reports grants, personal fees and non-financial support from Novartis Pharma, personal fees from Bristol–Myers Squibb and personal fees from Ariad during the conduct of the study. Luke Akard reports grants and personal fees from Teva, Ariad and Novartis, personal fees from Bristol–Myers Squibb and grants from Pfizer outside the conduct of the study. Elizabeth Li is employed by PharmaStat LLC, and reports payment for statistical analysis from Teva during the conduct of the study. Mihaela Munteanu reports employment by Teva during the conduct of the study. Jorge Cortes reports grants from Teva during the conduct of the study, and grants and personal fees from Ariad, Bristol–Myers Squibb, Novartis and Pfizer outside the submitted work. The remaining authors declare no conflict of interest.